Two Smaller Companies Worthy of Your "Attention"

Zacks Nov 25, 2024 15:35 ET

Elite Pharmaceuticals' Stock Up Despite Q2 Earnings Decline

Zacks Nov 18, 2024 11:15 ET

Elite Pharmaceuticals Receives FDA Approval on Its NDA for ADHD Treatment

Seeking AlphaNov 18, 2024 08:47 ET

ELITE PHARMACEUTICALS INC | 8-K: Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 ended September 30, 2024 and Provides Conference Call Information

SECNov 14, 2024 16:56 ET

ELITE PHARMACEUTICALS INC | 10-Q: Q2 2025 Earnings Report

SECNov 14, 2024 16:36 ET · Announcements

ELITE PHARMACEUTICALS INC (ELTP.US) will release financial reports after the market closes on November 14th.

$ELITE PHARMACEUTICALS INC(ELTP.US)$ will release its financial report after the market closes on November 14th. How was the previous performance? $ELITE PHARMACEUTICALS INC(ELTP.US)$ had a revenue of 18.803063 million USD, a net income of 0.615773 million USD, and an EPS of 0.000572 USD in 2025/Q1. The revenue in 2024/Q2 was 14.157185 million USD, with a net income of 14.934601 million USD.

Moomoo NewsNov 11, 2024 03:45 ET